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Abstract 
Menstrual pain which is severe enough to limit normal activities is termed as 
Kashtartava (dysmenorrhoea). Dysmenorrhoea is the most common gynecological problem 
faced by women due to abnormal anatomical and functional aspect of uterus, pschycosomatic 
factors, release of prostaglandins, pelvic congestion etc. Shankhapani Rasa which is a Herbo-
Mineral formulation posses all the contents having vatahara and gulmahara properties.The 
clinal Study was carried out to evaluate the efficacy of Shankhapani Rasa in patients 
suffering from Kashtartava by selecting 30 patients who attended the O.P.D. and I.P.D. of 
S.V.Ayurvedic Hospital Tirupathi during the period 2011-2012. Patients were given 
Shankhapani Rasa in a dose of 125mg capsules twice in a day for 1 month randomly and 
effect was evaluated on pre-test and post-test design.Statistically significant (p<0.01) results 
were seen in Subjective symptoms like pain during menstruation and duration of pain giving 
a conclusion that Shankhapani Rasa is effective in the management of Kashtartava. 
 
Key words: Kashtartava, Herbo-Mineral, Shankhapani Rasa 
 
Introduction 
Menstrual pain which is severe 
enough to limit normal activities is termed 
as Kashtartava (Dysmenorrhoea). 
Dysmenorrhoea is pain with menstruation 
usually craming in nature and centered in 
the lower abdomen.It is now estimated that 
almost 50% of all women experience some 
degree of dysmenorrhoea while 10% were 
incapacitated by it (1).Severe 
Dysmenorrhoea is most prevalent in young 
single women leading sedentary lives and 
its incidence becomes higher with the 
degree of civilization of the community 
(2). Keeping this in view, it was decided to 
conduct a study on most prevalent disorder 
in present times called Kashtartava. The 
drug chosen for the present study is 
Shankhapani Rasa, which was mentioned 
in Sahasrayogam, Gutika Yoga 
Prakaranam.Here the study is conducted 
for practical implication and clinical 
efficacy of Shankhapani Rasa in 
Kashtartava. 
 
Materials and methods: 
 Patients attending the O.P.D. and 
I.P.D. of S.V.Ayurvedic Hospital 
Tirupathi were selected. 
 The drug Shankhapani Rasa was 
prepared in the Department of R.S & 
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B.K, S.V Ayurvedic College, 
Tirupathi. 
 Total 33 patients with signs and 
symptoms of dysmenorrhea were 
registered. Out of which 30 patients 
completed the course of treatment. 
 
Trial drug: 
The drug chosen for the present 
study is Shankhapani Rasa (3) 
 
Table Showing the Ingredients of 
Shankhapani Rasa: 
S. 
No. 
Name of the 
drug 
Quantity Taken 
(gms) 
1.  Suddha Parada 48 (1pala) 
2.  Suddha 
Gandhaka 
48 (1pala) 
3.  Vatsanabha 
Churna 
48 (1pala) 
4.  Hingu Churna 96 (2pala) 
5.  Saindhava 
lavana 
384 (8 pala) 
6.  Chincha Kshara 384 (8 pala) 
7.  Shankha 
Bhasma 
384 (8 pala) 
8.  Sunthi Churna 96 (2 pala) 
9.  Maricha Churna 96 (2 pala) 
10.  Pippali Churna 96 (2 pala) 
11.  Nimbu Swarasa Q.S 
 
Method of preparation:  
Suddha Parada and Suddha 
Gandhaka were taken in Khalwa 
yantra.To this Shodhita 
Vatsanabhachurna, Hinguchurna, 
Saindhava lavana, Chincha Ksara, 
Shankha Bhasma, Trikatu churna were 
added. Bhavana was done with Nimbu 
swarasa for one day then dried and filled 
in 125mg capsules. 
 
Administration of the drug: 
Mode of administration – orally  
Dose – 125mg twice in a day 
Anupana – Hot water 
Duration of t/t- 1 Month (The drug was 
started Randomly) 
 Follow up- For 2 consecutive 
cycles 
 
Protocol: Randomized Open Labeled 
Clinical Trial protocols 
 
Plan of study 
 
Aims and objectives: 
The present clinical study has been 
planned to evaluate the efficacy of 
Shankapani Rasa in Kashtartava. 
 
Statistical criteria: 
  Patients were selected by random 
sampling technique i.e. irrespective of age, 
caste, religion & occupation, they were 
advised to visit the hospital every 2 weeks 
for regular check up & to assess the effect 
of the therapy there by.In case any patient 
leaves the treatment without completing 30 
days he / she will be declared as dropped 
out from the research work. 
 
Criteria for inclusion of the patients 
1. Pain during menstruation due to any 
cause (primary/secondary) except the 
causes mentioned in exclution criteria. 
2. Regular and Irregular cycles.  
 
Criteria for exclusion of the patients 
1. Rakta pradara (Dysmenorrhea with 
dysfunctional Uterine Bleeding)   
2. Malignancies 
3. Surgical conditions. 
 
Investigations: 
Laboratory investigations were 
carried out before and after treatment to 
rule out any other pathological conditions 
as well as to record any specific change by 
the treatment. 
 
Haematological:  
Routine hematological 
examinations like total leucocytes count, 
differential count, hemoglobin percent, 
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packed cell volume and erythrocyte 
sedimentation rate (Wintrobe's corrected 
method). 
 
Urine: Routine and microscopic 
examination. 
 
Sonography (U.S.G.): For uterine and 
adenexal study if needed to rule out any 
pathology or lesion. 
 
Criteria for assessment of the result: 
The improvement in the patients 
was assessed mainly on the basis of relief 
in the signs and symptoms of the disease. 
To assess the effect of therapy objectively, 
all the signs and symptoms were given 
scoring depending upon their severity. 
Dysmenorrhoea, the cardinal symptom 
assessed on its severity and duration of 
persistence.  
 
Assessment of Pain (Dysmenorrhoea): 
Severity of pain (Multidimensional 
scoring pattern) 
0  Menstruation is not painful and daily 
activity is unaffected 
 
1 
 Menstruation is painful and daily 
activity is not affected. No analgesic 
required 
 
2 
Menstruation is painful and daily 
activity is also affected. Analgesic 
drugs are needed 
 
3 
Menstruation is painful, she cannot do 
even her normal routine work and has 
to absent from class / office during.No 
effect even by taking analgesics. 
 
Duration 
 0  No pain in menstruation 
 1  Pain persists for less than 12 hours 
 2  Pain continues for 12 -24 hours 
 3  Pain continues for more than 24 hours 
 
Subjective criteria: Scoring pattern for 
general symptoms 
Table Showing scoring pattern 
None 0 
Mild 1 
Moderate 2 
Severe 3 
 
Assessment of total effect of therapy:- 
On the basis of improvement in the signs 
and symptoms of Kashtartava, the 
following criteria were followed to 
evaluate the total efficacy of the therapy. 
Table showing percentage relief obtained 
by the Therapy:  
 
Percentage of 
relief 
Effect 
>76% Cured 
51-75% Markedly improved 
26-50% Improved 
<25% No improvement 
 
STATISTICAL EVALUATION OF 
RESULTS 
The obtained information was 
analyzed statistically in terms of mean 
score (x), Standard Deviation (S.D.), 
Standard Error (S.E.).Paired t-Test was 
carried out at the level of 0.05, 0.01, and 
0.001 of P levels. For the more 
effectiveness of therapy paired t-Test is 
carried out. The results were interpreted as  
a) P > 0.05 : Insignificant 
b) P < 0.05  : Significant 
c) P < 0.01 & 
<0.0001 
: Highly significant 
 
Presentation of data: 
The data collected & analyzed has been 
depicted in the following sequence: 
1. General observations viz. age, 
occupation, religion etc. 
2. Results of therapy evaluated on the 
basis of improvement in 
symptomatology. 
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OBSERVATIONS AND RESULTS 
1. Age wise distribution: 
Table Showing Age wise distribution of Kashtartava in 30 patients 
 S.No. Age Number of patients % of distribution 
1.  20-30 15 50 
2.  30-40 10 33.33 
3.  40-50 05 16.67 
Maximum number of patients belongs to age group, 20-30 yrs. (50%), followed by 30-40 
yrs (33.3%) and 40-50 yrs (16.67%). 
 
2. Religion wise distribution: 
Table Showing Religion wise distribution of 30 patients: 
 S.No.  Religion Number. of Patients % of Distribution 
1.  Hindu 25 83.33 
2.  Muslim 05 16.67 
Maximum number of patients were Hindus (83.33%) and rest were Muslims (16.67%). 
 
3. Marital status wise distribution: 
Table Showing Marital status wise distribution of 30 patients: 
 S.No. Marital status Number of patients % of Distribution 
1.  Married 20 66.67 
2.  Unmarried 10 33.33 
Maximum number of patients were married (66.67 %) followed by unmarried (33.33%). 
 
4. Nature of work wise distribution: 
Table Showing Nature of work wise distribution of 30 patients 
S.No. Nature of work Number of patients % of distribution 
1.  House wife 15 50% 
2.  Student 10 33.33% 
3.  Labour 5 16.67% 
Maximum number of patients were housewives (50 %) followed by students (33.33%), and 
labourers (16.67%). 
 
5. Food habits wise distribution: 
Table Showing Food habits wise distribution of 30 Patients: 
 S.No.  Food Habits Number of patients % of Distribution 
1.   Vegetarian 10 33.33% 
2.  Non-vegetarian 20 66.67% 
Maximum number of patients were Non Vegetarians (66.67 %) and rest were vegetarians 
(33.33 %). 
 
6. Predominant rasa wise distribution: 
Table Showing the Predominant rasa wise distribution of 30 patients: 
 S.No. Predominant rasa Number of Patients % of Distribution 
1.  Madhura-Amla 8 26.67% 
2.  Lavana-Amla 10 33.33% 
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3.  Katu-Tikta 12 40% 
Maximum number of patients were habituated to take Katu-Tikta rasa predominant diet 
(40%), followed by Lavana-Amla rasa (33.33%), Madhura-Lavana rasa (26.67%). 
 
7. Constipated Bowel during menstruation wise distribution: 
Table Showing the Constipated Bowel wise distribution of 30 patients: 
S.No. Constipated Bowel Number of patients % of distribution 
1.  Present 24 80% 
2.  Absent 6 20% 
 Maximum number of patients had Constipated bowels during mentruation (80 %) and rest 
(20%) of patients had no Constipated bowels during menstruation. 
 
8. Chronicity wise distribution: 
Table Showing the Chronicity wise distribution of 30 patients: 
S.No. Chronicity Number of 
Patients 
% of distribution 
1.  1-5 yr 12 40% 
2.  5-10yr 9 30% 
3.  10-15yr 9 30% 
 Maximum number of patients had been suffering since 1-5 years (40 %), 5-10 years (30 %) 
and 10-15 years (30 %). 
 
9. Parity wise distribution: 
Table Showing the Parity wise distribution of 30 patients: 
S.No Parity Number of Patients % of Distribution 
1.  Nulliparous 14 46.66 
2.  Primiparous 05 16.67 
3.  Multiparous 11 36.67 
Maximum number of patients were nulliparous (46.66%) followed by multiparous (36.67%), 
and primiparous (16.67 %) 
 
10. Deha prakruti wise distribution: 
Table Showing the Deha prakruti wise distribution of 30 patients: 
 S.No.  Deha prakriti Number of Patients % of Distribution 
1.  Vata-pitta 17 56.66 
2.   Vata-kapha 9 30.00 
3.   Kapha-pitta 4 13.33 
Maximum number of patients were Vata-pittaja prakriti (56.66%) followed by Vata- Kaphaja 
prakriti (30.00 %) and Kapha- Pittaja prakriti (13.33 %). 
 
11. Family history wise distribution: 
Table Showing the Family history wise distributionof 30 Patients: 
 S.No. Family history Number of patients  % distribution 
1.  Present 12 40% 
2.  Absent 18 60% 
Maximum number of patients had no family history (60%) and rest had family history (40 %) 
related to Kashtartava. 
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12. Regularity of menstrual cycle wise distribution 
Table Showing the Regularity of menstrual cycle wise distribution: 
S.No. Regularity Number of patients % distribution 
1.  Regular 22 73.33% 
2.  Irregular 08 26.67% 
 
Maximum number of patients are having regular menstrual cycles (73.33%) and rest are 
having irregular menstrual cycles (26.67 %). 
 
13. Onset of pain wise distribution of 30 patients: 
Table Showing the Onset of pain wise distribution of 30 patients: 
S.No. Onset of pain Number of patients %distribution 
1.  Few hours Before menstruation 18 60.00 
2.  After menstruation 12 40.00 
 
Maximum number of patients are suffering from pain a few hours before menstruation (60%) 
and rest are having pain after onset of menstruation (40 %). 
 
14. Severity of pain wise distribution of 30 patients: 
Table Showing the Severity of pain wise distribution of 30 patients: 
 S.No. Severity of pain Number.of patients  %distribution 
1.  Grade 1 09  30 
2.  Grade 2 13  43.33  
3.  Grade 3 08  26.66 
 
Maximum number of patients are having Grade 2 Severity of pain (43.33%) followed by 
Grade 1 Severity of pain (30%).  
 
15. Duration of Pain wise distribution of 30 patients: 
Table Showing the Duration of Pain wise distribution of 30 patients: 
 S.No. Duration of pain Number of patients  %distribution 
1.  < 12 hours 09  30 
2.  12- 24 hours 14  46.66 
3.  > 24 hours 07  23.33 
 
Maximum number of patients are having 12-24 hrs duration of pain (46.66%) followed by 
(30%) having <12 hrs duration of pain. 
 
16. Effect of Shankhapani Rasa on subjective parameters in 30 patients: 
Table Showing the Effect of Shankhapani Rasa on subjective parameters: 
Symptoms N B.T A.T Mean Relief 
% 
S.D S.E ‘t’ p 
Severity of 
pain 
30 1.966 0.366 1.6 81.35% 0.56 0.102 15.55 0.0003 
Duration 30 1.933 0.33 1.6 82.75% 0.674 0.123 12.99 0.0002 
 
This table shows that Shankhapani Rasa provided statistically highly significant relief 
(p<0.01) of 81.35% in Severity of pain and 82.75% relief (p <0.01) in duration. 
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Showing the overall Assessment of Clinical trial: 
 Result  Number of patients  % patients 
Cured  21 70 
Moderately cured 06 20 
Not cured 03 10 
   
Discussion: 
Dysmenorrhea i.e, pain during 
menstruation is becoming a challenging 
problem for women.It is commonly 
prevalent from the age of 16 to 30 years. 
The present study is under taken to find 
a complete and safe solution for 
Kashtartava through Ayurveda. 
Ayurveda is an ocean and to take 
out a pearl i.e., treatment for any ailment is 
the work of Physician. It is mentioned in 
Ayurvedic classics that physician basing 
on his knowledge and condition of the 
patient must decide the drug to be 
administered. There are various 
formulations mentioned for treatment of 
Kashtartava. Shankhapani Rasa which 
was mentioned in Sahasra Yogam in 
Gutika prakarana consists of Kajjali, 
Chincha Ksara, Trikatu churna, Suddha 
Hingu, Suddha Vatsanabha, Saindhava 
lavana and Shankha Bhasma. 
Maximum number of patients 
(83.33%) belonged to Hindu religion. As 
the Study was conducted in Hindu 
predominant area, this finding was 
observed. Eventhough in the present study 
maximum number of patients (50%) were 
married, they were having this problem 
since menarchae. Therefore the relation 
between marriage and dysmenorrhoea 
cannot be attributed. It is observed that 
maximum number, of patients were 
Housewifes (50%). The patients who 
attended to our hospital were mainly 
housewifes. Maximum number of patients 
reported in present study were Non-
vegetarians (66.67%). Even though it is 
one of the upashaya of Kashtartava as 
they were taking it only once/twice in a 
month, it could not decrease the problem 
in those cases. 
It is observed that maximum 
number of patients (40%) was taking 
Katu-Tikta rasa predominant ahara. This 
shows the role of Katu rasa in the 
vitiation of vata, which is the chief cause 
in the manifestation of Kashtartava. 
Maximum number of patients (80%) had 
Constipated bowels during menstruation, 
this reflects the vitiation of Apana Vata 
which is an important cause for 
Kashtartava. Present study shows that 
maximum percentage (40%) of patients 
were suffering from Kashtartava since 1-5 
years, this shows the chronicity of the 
disease.  
Maximum numbers of patients 
registered were nulliparous (46.66%).In 
these cases dysmenorrhoea might be due 
to the narrow pathway. Incidence 
according to prakriti showed that the 
majority of patients (56.66%) were Vata-
Pittaja followed by Vata-Kaphaja (30%). 
This observation supports the involvement 
of Vata Dosha in the pathogenesis of 
disease. In the present study 40% of 
patients were shown to have the family 
history of the disease, hence there might 
be the possibility of occurrence of 
the disease in the family. 
All the patients were suffering 
from pain, either, 2-3 hours before the 
onset of menstruation or during 
menstruation. This also confirms the 
diagnosis as Primary dysmenorrhoea. 
Statistically highly significant 
relief of 81.35%, was observed in 
severity of pain. Statistically highly 
significant relief of 82.75%, was 
observed in duration of pain.  
Trikatu have deepana, pachana 
and shulaprasamana properties hence it 
helps in reducing the pain which is 
produced by ama (4). Vatsanabha has the 
properties madhura rasa, ushna virya and 
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madhura vipaka., therefore acts as vata 
samaka (5). Hingu is having sula hara, 
Anulomaniya and Vata-Kapha hara 
properties
 
(6). Shankha is having 
Sulahara, Gulmahara and udaramayahara 
properties
 
(7). Saindhava lavana has 
rochana, deepana properties (8).As the 
Kshara is having lekhana property it 
scapes the excessive doshas and dhatus 
from its place and thus helps in relieving 
the pain which may be due to obstruction 
of the srotas by the vitiated doshas (9). 
Nimbuka has deepana, pachana and 
sulahara properties (10). 
 
Conclusion: 
Clinically the drug Shankhpani 
Rasa was found to cure 70% patients 
completely without remission of 
symptoms especially in Severity of pain 
and duration of pain after cessation of 
therapy, 20% of the patient had moderate 
relief in symptoms and only 10% of 
patients found no relief. Therapy was 
efficacious on all the major symptoms of 
the disease.  
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